Matches in Nanopublications for { ?s ?p "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP148037.RATiKkqVOOsNrZTLIuEv7-Y52-5O2bYCqtcAzjLpyx1AM130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148037.RATiKkqVOOsNrZTLIuEv7-Y52-5O2bYCqtcAzjLpyx1AM130_provenance.
- NP148038.RAUvXk944oRNRfYowb1wsl-39RSUAvant0X7i1W65Wd_Y130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148038.RAUvXk944oRNRfYowb1wsl-39RSUAvant0X7i1W65Wd_Y130_provenance.
- assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP211167.RAc3O1AYi94cknH-Uz5OEh1qLdQHU_qgAI1J2tdTf2mrM130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211167.RAc3O1AYi94cknH-Uz5OEh1qLdQHU_qgAI1J2tdTf2mrM130_provenance.
- NP226208.RACqrrchdhIzIoaBYE6Jz1VD_SMbThNoE_LrglwL2MRUU130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226208.RACqrrchdhIzIoaBYE6Jz1VD_SMbThNoE_LrglwL2MRUU130_provenance.
- NP211168.RAO0SstwkXplcYTDie7XqjBEjDlcrM6Jiukjx0a1iKGUU130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211168.RAO0SstwkXplcYTDie7XqjBEjDlcrM6Jiukjx0a1iKGUU130_provenance.
- NP226209.RAM3m-1XuzCs87Jl-xkjQlh1EMuXwSv4v0o9UV_fMsXEY130_assertion description "[LA's ability to inhibit apoptosis and proliferation of ECs could beneficially affect endothelial dysfunction, which precedes manifestation of late diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226209.RAM3m-1XuzCs87Jl-xkjQlh1EMuXwSv4v0o9UV_fMsXEY130_provenance.